Panacea gets US patent for haemorrhoids drug
MUMBAI, July 9 (Reuters) - Drugmaker Panacea Biotec Ltd (PNCA.BO: Quote, Profile, Research) said on Wednesday it has secured a patent from the United States Patent and Trademark Office for haemorrhoids treatment drug.
Panacea plans to launch the drug 'Thank God,' chemically called euphorbia prostrata, in the U.S. and Europe, where the market size for the product is estimated between $500 million and $600 million.
Ahead of the news, the shares closed 2.4 percent lower at 314.60 rupees in a firm Mumbai market. (Reporting by Bharghavi Nagaraju; Edited by Ramya Venugopal)
© Thomson Reuters 2009 All rights reserved
India Investment Summit 2009
Top executives and bankers discuss their own plans and the broader opportunities and challenges for India. Full Coverage
PLAYBOY SALE
An icon bows to changing times
With his Playboy Enterprises in talks to be sold for about $300 million, the 83 year-old Hugh Hefner will be giving up control over the iconic adult entertainment empire he founded that was instrumental in shaping society's opinions on nudity, sex and free speech. Full Article
India
US
UK
